Arisan Therapeutics, Inc.

This early-stage study tested a new oral drug called ARN-75039, being developed to treat Lassa fever, a serious viral illness. The trial involved 94 healthy adults to check the drug's safety and how the body processes it. Participants received either the drug or a placebo in sing…

This study tested two versions of the drug ARN-75039 in 16 healthy adults to see how well each is absorbed after a meal. One version is a tablet with extra ingredients, the other is a plain capsule. Participants took both forms one week apart, and researchers measured drug levels…